Skip to content

World Vaccine Congress Europe

In-Person Event Mon 19 Oct 2026 Amsterdam, Netherlands
Early Phase Clinical Consulting Infectious Diseases

Accelerate Vaccine Development Through Collaboration and Innovation hVIVO will be attending the World Vaccine Congress Europe, one of the leading global forums dedicated to the end-to-end development ...

Accelerate Vaccine Development Through Collaboration and Innovation 


hVIVO will be attending the World Vaccine Congress Europe, one of the leading global forums dedicated to the end-to-end development of vaccines—from early research and clinical trials through to manufacturing, access, and global health delivery. The event brings together senior leaders across pharma, biotech, academia, and public health to address the most pressing challenges in vaccine development.

Our team will be on-site to discuss how our expertise in human challenge trials, early-phase clinical development, and infectious disease can support vaccine programmes at every stage. We welcome the opportunity to connect with partners looking to optimise trial design, accelerate timelines, and generate high-quality data in complex and fast-moving therapeutic areas.

Conference Highlights

  • Covers the full vaccine lifecycle—from immune profiling and clinical development to global access and delivery

     

  • Focus on next-generation vaccine technologies, including immunotherapy and novel platforms

     

  • Dedicated tracks on infectious diseases, including influenza, respiratory viruses, and emerging pathogens

     

  • Insights into clinical trials, regulatory pathways, and accelerating vaccine candidates to licensure

     

  • Strong emphasis on partnerships, funding, and global market access

     

  • 150+ solution providers and extensive networking with global vaccine experts

     

  • Interactive working groups and collaboration-led sessions to solve industry challenges